NCT05034627
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Stage IIB Pancreatic Cancer AJCC v8
Explore clinical trials studying Stage IIB Pancreatic Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
10 public trials
0 recruiting studies
Stage IIB Pancreatic Cancer AJCC v8 trial results
NCT04106856
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
NCT04449679
- Conditions
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage 0 Gastric Cancer AJCC v8, +98 more
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
NCT03784677
- Conditions
- Adnexal Diseases, Advanced Malignant Solid Neoplasm, Digestive System Diseases, +44 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
NCT05055323
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
NCT04887805
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
NCT04940286
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +11 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
NCT04821284
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
- Haukeland University Hospital Bergen, Norway
Active, Not Recruiting
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
NCT04111172
- Conditions
- Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, +50 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States